SEC Original – Page 1224 – China Stock Advice

LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT RESIGNATION OF NON-EXECUTIVE DIRECTOR Board Company The board of directors (the Mr. Zhang Xiangxian has confirmed that he has no disagreement with the Board and there are no other matters relating to his resignation that] [Description 99.1 Announcement, dated August 4, 2016 China Life Insurance Company Limited]

By info| 2016-08-05T02:35:56+00:00 August 4th, 2016|Categories: Chinese Stocks, LFC, SEC Original|Tags: 0001268896, 2016-08-04, 6-K, 6311, LFC, LIFE INSURANCE|0 Comments

CISG [CNINSURE] SC 13G/A: (Original Filing)

[JOINT FILING AGREEMENT This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] Qiuping Lai Qiuping Lai Crown Charm Limited Qiuping Lai Director Guangzhou Huajie Insurance Agency Co., Ltd. Qiuping Lai Director] [Qiuping Lai 2 Check the Appropriate Box if a Member of a Group ¨ (a) x (b) 3 SEC Use Only 4 Citizenship or Place of Organization People’s Republic of China Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 1 218,659,360 6 Shared Voting Power 0 7 Sole Dispositive Power]

By info| 2016-08-05T02:39:29+00:00 August 4th, 2016|Categories: Chinese Stocks, CISG, SEC Original|Tags: 0001413855, 2016-08-04, 6411, CISG, INSURANCE AGENTS BROKERS and SERVICES, SC_13G.A|0 Comments

HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)

[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) 2016 Interim Results Announcement Consolidated operating revenue: RMB52.924 billion Net profit attributable to equity holders of the Company: RMB6.177 billion Earnings per share: RMB0.41 INTERIM RESULTS The Board of Directors of Huaneng Power International, Inc. (the “Company”) announces the]

By info| 2016-08-05T02:41:20+00:00 August 4th, 2016|Categories: Chinese Stocks, HNP, SEC Original|Tags: 0000929058, 2016-08-04, 4911, 6-K, ELECTRIC SERVICES, HNP|0 Comments

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Announces Formation of Special Committee to Evaluate Proposed Transaction SHANGHAI, August 4, 2016 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that the Company’s Board of Directors, with the unanimous agreement of all directors,] []

By info| 2016-08-05T02:47:08+00:00 August 4th, 2016|Categories: Chinese Stocks, OSN, SEC Original|Tags: 0001485538, 2016-08-04, 3312, 6-K, OSN, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

CNIT [China Information Technology] 6-K: (Original Filing)

[FORM 6-K August 2016 001-35722 CHINA INFORMATION TECHNOLOGY, INC. 21 st Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong, 518040 Peoples Republic of China Note Note: On July 29, 2016, Mr. Guanguyuan Zong resigned from his position as Chief Marketing Officer of China Information Technology, Inc. (the Company). Mr. Zongs resignation was due to personal reasons and was not]

By info| 2016-08-05T02:49:40+00:00 August 4th, 2016|Categories: Chinese Stocks, CNIT, SEC Original|Tags: 0001552670, 2016-08-04, 6-K, 7372, CNIT, SERVICES-PREPACKAGED SOFTWARE|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE August 4, 2016 China Biologic Reports Financial Results for the Second Quarter of 2016 --2Q16 Total Sales Up 23.4% with Non-GAAP Net Income Up 31.3% YoY in RMB terms, or Up 15.5% YoY to $91.4 Million and 23.1% YoY to $35.2 Million in USD terms, respectively --1H16 Total Sales Up 26.2% with Non-GAAP Net Income Up 30.6% YoY] []

By info| 2016-08-05T02:52:28+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2016-08-04, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] IRANNOTICE: (Original Filing)

[China Biologic Products, Inc. 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China August 4, 2016 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]

By info| 2016-08-05T02:54:35+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2016-08-04, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, IRANNOTICE|0 Comments

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[Melco Crown Entertainment Announces Unaudited Second Quarter 2016 Earnings and Declares Quarterly Dividend Macau, Thursday, August 4, 2016 Melco Crown Entertainment Company we Net revenue for the second quarter of 2016 was US$1,070.4 million, representing an increase of approximately 17% from US$916.8 million for the comparable period in 2015. The increase in net revenue was primarily attributable to the net] [Form 6K TABLE OF CONTENTS MELCO CROWN ENTERTAINMENT LIMITED Geoffrey Davis, CFA Chief Financial Officer 3]

By info| 2016-08-05T02:07:21+00:00 August 4th, 2016|Categories: Chinese Stocks, MPEL, SEC Original|Tags: 0001381640, 2016-08-04, 6-K, 7011, HOTELS and MOTELS, MPEL|0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,] [Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)] [CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant] [Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer]

By info| 2016-08-05T02:57:03+00:00 August 4th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 10-Q, 2016-08-04, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

NPD [China Nepstar Chain Drugstore] 25-NSE: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:] []

By info| 2016-08-05T02:11:01+00:00 August 4th, 2016|Categories: Chinese Stocks, NPD, SEC Original|Tags: 0001414850, 2016-08-04, 25-NSE, 5912, NPD, RETAIL-DRUG STORES AND PROPRIETARY STORES|0 Comments